About 200 reports

  • Target
  • Clinical Trial profile. 148 Trial Title
  • Blood Disease
  • Blood Supply
  • Cell Therapy
  • Clinical Trial
  • World
  • Therapy Area Indication(s)
  • Cell Therapy
  • Clinical Trial
  • Drug Discovery And Development
  • World
  • Product Initiative
  • FILGRASTIM - DRUG PROFILE
  • Biotech
  • Cell Therapy
  • Pharmaceutical
  • Stroke
  • Athersys, Inc.

FILGRASTIM - DRUG PROFILE Drug Name Company/ Institute Name Licensed From Company Development Partner Product Description FILGRASTIM NA NA FRAUNHOFER INSTITUTE FOR CELL THERAPY AND IMMUNOLOGY GRANULOCYTE COLONY-STIMULATING FACTOR (G-CSF) IS UNDER DEVELOPMENT FOR THE TREATMENT O

  • Biotech
  • Cell Therapy
  • United States
  • World
  • Product Initiative

Filgrastim, and Plerixafor in Improving Stem Cell Mobilization in Treating Patients with Non-Hodgkin Lymphoma GDCT## NCT##, CASE##; NCI-2011-##; CDR##; P##CA## Oncology Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia), Anaplastic Large Cell Lymphoma (ALCL)

  • Cancer
  • Cell Therapy
  • United States
  • World
  • Product Initiative
  • Clinical Trial profile. 51 Trial Title
  • Clinical Trial profile. 87 Trial Title

filgrastim; sargramostim Emory University ## Apr 2004 ## Jan 2015 ## ## ## ## ## Granulocyte Colony Stimulating Factor Receptor (CD## or GCSFR or CSF##R) Agonist Granulocyte Colony Stimulating Factor Receptor (CD## or GCSFR or CSF##R) Trial Status Trial Phase Study Type Drug(s)/ Molecule(s)

  • Cell Therapy
  • Leukemia
  • World
  • Product Initiative
  • Celgene Corporation

Filgrastim in Treating Patients with Burkitt' s Lymphoma or Burkitt' s Leukemia GDCT## NCT##, U##CA##; CALGB-##; CDR## Oncology Burkitt Lymphoma, Leukemias, Lymphoma Completed Phase II Interventional allopurinol; cyclophosphamide; cytarabine; dexamethasone; doxoru

  • Cell Therapy
  • HIV AIDS
  • Lymphoma
  • World
  • Product Initiative
  • Clinical Trial profile. 161 Trial Title
  • 5. All the trials included are unique trials.

filgrastim; sargramostim Fred Hutchinson Cancer Research Center ## Mar 1995 ## Oct 1997 ## ## Clinical Trial profile. ## Trial Title Official Title Trial Identifier Secondary ID(s) Therapy Area Indication(s) Trial Status Trial Phase Study Type Drug(s)/ Molecule(s) Sponsor(s) Collaborato

  • Biological Therapy
  • Blood Disease
  • Cell Therapy
  • World
  • Product Initiative

Filgrastim or Lenograstim or CSF##)) Completed Phase I Interventional busulfan; filgrastim; melphalan; peripheral blood stem cells; thiotepa Fred Hutchinson Cancer Research Center National Cancer Institute US ## Mar 1998 ## Jan 2002 ## ## ## ## A Phase I Study of the Chemoprotectant A

  • Cancer
  • Cell Therapy
  • World
  • Product Initiative
  • Eli Lilly & Co.
  • Clinical Trial profile. 247 Trial Title
  • Cancer
  • Cell Therapy
  • United States
  • World
  • Novartis AG
  • Clinical Trial profile. 24 Trial Title

Flexible Filgrastim to Accelerate Bone Marrow Recovery after Chemotherapy in Children with Cancer GDCT## NCT##, 2013-##; NCI-2013-02001; 2013-##; P##CA##; CDR## Oncology Brain Tumor, Germ Cell Tumors, Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma), Medulloblastoma, Neuroblastom

  • Cell Therapy
  • Chemotherapy
  • Clinical Trial
  • United States
  • World

Mast Cell Leukemia Global Clinical Trials Review, H##, 2017 HEA LTH CA REHEA LTH CA RE REFERENCE CODE: GDHC##CTIDB PUBLICATION DATE: DEC 2017 LIST OF TABLES Mast Cell Leukemia Global Clinical Trials Review, H##, 2017 outlines clinical trials in Mast Cell Leukemia.

  • Cell Therapy
  • Leukemia
  • World
  • Product Initiative
  • Novartis AG
  • Clinical Trial profile. 61 Trial Title

filgrastim ## fludarabine anti-thymocyte globulin busulfan ## ## ## plerixafor ## Total Source: GlobalData' s Pharma Intelligence Center Clinical Trials Database (*)Trials are taken for a time period of 1995 - 2017 2017 trials are taken as of August 2017 ## CLINICAL TRIAL PROFILE SNAPSHOTS N

  • Blood Disease
  • Cell Therapy
  • Therapy
  • World
  • Product Initiative

filgrastim ## FLX-## ## ibudilast ## Total Source: GlobalData' s Pharma Intelligence Center Clinical Trials Database (*)Trials are taken for a time period of 1995 - 2017 2017 trials are taken as of March 2017 ## Latest Clinical Trials News on Amyotrophic Lateral Sclerosis MAR ##, 2017: CO

  • Cell Therapy
  • Clinical Trial
  • Drug Discovery And Development
  • World
  • Product Initiative

Filgrastim or Pegfilgrastim in Treating Patients with Recurrent or Persistent Cancer of the Uterus GDCT## NCT##, CDR##; GOG-##G; NCI-2012-##; U##CA##; CDR## Oncology Leiomyosarcoma, Sarcomas, Uterine Cancer Completed Phase II Interventional docetaxel;

  • Cell Therapy
  • Clinical Trial
  • Drug Discovery And Development
  • World
  • Product Initiative
  • Blood Disease
  • Cell Therapy
  • Pathology
  • United States
  • Product Initiative
  • Clinical Trial profile. 228 Trial Title

filgrastim; ifosfamide; melphalan; methotrexate; methylprednisolone; pegfilgrastim; prednisolone; rituximab; vincristine sulfate; vindesine sulfate University Hospital Essen Deutsche Krebshilfe eV ## Nov 2007 ## Mar 2017 ## ## ## ## ## DNA Synthesis Inhibitor DNA Clinical Trial profile. ##

  • Cell Therapy
  • Lymphoma
  • Monoclonal Antibody
  • World
  • Product Initiative
  • Clinical Trial profile. 2315 Trial Title
  • Clinical Trial profile. 1675 Trial Title

Filgrastim or Lenograstim or CSF##)) Completed Phase III Interventional amsacrine; autologous peripheral blood stem cells; carmustine; cytarabine; etoposide; filgrastim; idarubicin; mitoxantrone European Organization for Research and Treatment of Cancer Gruppo Italiano Malattie EMat

  • Cell Therapy
  • Drug Discovery And Development
  • Leukemia
  • United States
  • World

Filgrastim or Lenograstim or CSF##)) Completed Phase I Interventional busulfan; filgrastim; melphalan; peripheral blood stem cells; thiotepa Fred Hutchinson Cancer Research Center National Cancer Institute US ## Mar 1998 ## Jan 2002 ## ## ## ## Official Title Clinical Trial profile. ##

  • Cancer
  • Cell Therapy
  • United States
  • World
  • Novartis AG
  • (FILGRASTIM + PLERIXAFOR) - DRUG PROFILE
  • DORMANT PROJECTS, H1 2016
  • Cancer
  • Cell Therapy
  • R&D
  • Research And Development
  • BioLineRx Ltd.
  • Clinical Trial profile. 1058 Trial Title
  • Clinical Trial profile. 500 Trial Title

filgrastim; fludarabine phosphate; melphalan; natural killer cells; rituximab; T cell-depleted hematopoietic stem cells; thiotepa St.

  • Cell Therapy
  • Monoclonal Antibody
  • Pharmaceutical
  • United States
  • World
  • Clinical Trial profile. 133 Trial Title
  • Clinical Trial profile. 173 Trial Title

Filgrastim-Mobilized Peripheral Blood Stem Cells for Allogeneic Transplantation with Unrelated Donors Filgrastim-Mobilized Peripheral Blood Stem Cells for Allogeneic Transplantation with Unrelated Donors GDCT## NCT##, UC-##; ##-CC-##; NCT## Immunology Hematopoiet

  • Blood Supply, Tissue Banking And Transplantation
  • Cell Therapy
  • Clinical Trial
  • World
  • Product Initiative

Earlier in his career, he led development of cellular therapies at Amgen Inc. as laboratory head in the Department of Developmental Hematology, where he was also involved in the development of Filgrastim, Neulasta and Stemgen.

  • Cell Therapy
  • Heart Failure
  • United States
  • Product Initiative
  • BioCardia, Inc.

Filgrastim in Promoting Stem Cell Mobilization in Patients with Non-Hodgkin Lymphoma or Multiple Myeloma Undergoing Stem Cell Transplant GDCT## NCT##, NCI-2012-##; 2008-##; P##CA## Oncology B-Cell Chronic Lymphocytic Leukemia, Burkitt Lymphoma, Diffuse Large B-Cell Lymphoma

  • Cell Therapy
  • Leukemia
  • Monoclonal Antibody
  • World
  • Product Initiative
  • Cancer
  • Cell Therapy
  • Pathology
  • World
  • Product Initiative
  • Clinical Trial profile. 918 Trial Title

Filgrastim Versus Placebo Following Allogeneic Bone Marrow Transplantation Trial of Filgrastim Versus Placebo Following Allogeneic Bone Marrow Transplantation GDCT## NCT##, Immunology Graft Versus Host Disease (GVHD) Completed Phase III Interventional

  • Cell Therapy
  • Drug Discovery And Development
  • Pharmaceutical
  • United States
  • World
  • Clinical Trial profile. 90 Trial Title

filgrastim; melphalan Boston Medical Center National Institutes of Health ## Nov 2000 ## Jun 2005 ## ## ## ## ## DNA Synthesis Inhibitor DNA A Multicenter Phase II Trial of Bortezomib (Velcade), Melphalan and Dexamethasone (V-MD) in Patients with Symptomatic AL-Amyloidosis or Light Chain Depo

  • Cell Therapy
  • Clinical Trial
  • Therapy
  • World
  • Product Initiative

Filgrastim targets G-CSF receptor.

  • Cell Therapy
  • Transplantation
  • United States
  • Product Initiative
  • Pluristem Therapeutics Inc.
  • FILGRASTIM - DRUG PROFILE
  • Cell Therapy
  • Gene Therapy
  • United States
  • Product Initiative
  • Merck & Co., Inc.

filgrastim; prednisone; rituximab; vincristine The Alliance for Clinical Trials in Oncology Montefiore Medical Center ## May 2005 ## May 2018 ## ## ## ## ## Cytotoxic To Cells Expressing B Lymphocyte Antigen CD## (B Lymphocyte Surface Antigen B## or Bp## or Leukocyte Surface Antigen Leu ##

  • Cell Therapy
  • Lymphoma
  • Monoclonal Antibody
  • United States
  • World